{
  "retracted": false,
  "timestamp": 1343952000000,
  "updates": [
    {
      "timestamp": 1585345387799,
      "identifier": {
        "doi": "10.1038/gim.2012.62"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/gim.2012.39"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: CORRIGENDUM: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)"
}
